{"created":"2023-06-20T14:25:17.725987+00:00","id":405,"links":{},"metadata":{"_buckets":{"deposit":"e1ae69e4-f506-4f82-aebd-19320a9476cf"},"_deposit":{"created_by":3,"id":"405","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"405"},"status":"published"},"_oai":{"id":"oai:dmu.repo.nii.ac.jp:00000405","sets":["81:35"]},"author_link":["1659","1658"],"item_2_biblio_info_12":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2005-10-25","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"3","bibliographicPageEnd":"246","bibliographicPageStart":"241","bibliographicVolumeNumber":"32","bibliographic_titles":[{"bibliographic_title":"Dokkyo journal of medical sciences"}]}]},"item_2_description_10":{"attribute_name":"抄録(日)","attribute_value_mlt":[{"subitem_description":"肝癌は障害肝に発生することが多いため,腫瘍条件と肝機能を考慮して手術適応を決める必要がある.腫瘍数が3個以内の症例を適応とするが,腫瘍数の診断にはCTAPが最も有用である.実際,腹水の有無,総ビリルビン値,補正ICG15分値に基づき手術適応,術式を決定する.最終的にはCTvolumetryを行い,非癌部肝実質切除量を計測し,術式の妥当性を判断し,必要あれば門脈右枝塞栓術を施行する.手術は解剖学的切除(葉切,区域切除,系統的亜区域切除)を可及的に施行するようにし,術中輸液量および一回換気量の減量,肝下部下大静脈遮断などを併用して出血量を減らす努力を行うことで,平均出血量714.4±743.8mlで,輸血率は5%であった.また,術後1ヶ月以内の死亡例はない.今後,生体肝移植のオプションも加わり,肝癌に対する外科的治療は飛躍的に発展するものと考えられる.","subitem_description_type":"Other"}]},"item_2_description_11":{"attribute_name":"抄録(英)","attribute_value_mlt":[{"subitem_description":"Since most hepatocellular carcinomas (HCC) develop in the damaged liver, indication of surgery should be decided on the basis of tumor condition and liver function. At my department, in addition to presence or absence of ascites, total bilirubin level in the serum, and ICGR15, CT volumetry are employed in order to decide a surgical indication including indication of portal embolization. Anatomical resection is employed as much as possible. Intraoperative bleeding is decreased by reduction of infusion volume and tidal volume, and infra-hepatic IVC clamping, resulting in a mean bleeding amount of 714.4±743.8ml without any postoperative mortality within one month. Now, surgical treatment for HCC is developing dramatically by employing option of living-related liver transplantation.","subitem_description_type":"Other"}]},"item_2_description_8":{"attribute_name":"記事種別(日)","attribute_value_mlt":[{"subitem_description":"特集","subitem_description_type":"Other"}]},"item_2_description_9":{"attribute_name":"記事種別(英)","attribute_value_mlt":[{"subitem_description":"Special Edition","subitem_description_type":"Other"}]},"item_2_source_id_1":{"attribute_name":"雑誌書誌ID","attribute_value_mlt":[{"subitem_source_identifier":"AA00629581"}]},"item_2_source_id_19":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"03855023","subitem_source_identifier_type":"ISSN"}]},"item_2_text_6":{"attribute_name":"著者所属(日)","attribute_value_mlt":[{"subitem_text_value":"獨協医科大学 第二外科学"}]},"item_2_text_7":{"attribute_name":"著者所属(英)","attribute_value_mlt":[{"subitem_text_language":"en","subitem_text_value":"Dokkyo University School of Medicine"}]},"item_2_title_3":{"attribute_name":"論文名よみ","attribute_value_mlt":[{"subitem_title":"カンガン ノ ゲカテキ チリョウ : カン イショク モ フクメテ"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"窪田, 敬一"},{"creatorName":"クボタ, ケイイチ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"Kubota, Keiichi","creatorNameLang":"en"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2017-05-24"}],"displaytype":"detail","filename":"KJ00004451254.pdf","filesize":[{"value":"1.8 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"KJ00004451254.pdf","url":"https://dmu.repo.nii.ac.jp/record/405/files/KJ00004451254.pdf"},"version_id":"bf70c507-d2d9-4504-b959-6834493a3eba"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"肝癌"},{"subitem_subject":"肝切除"},{"subitem_subject":"肝移植"},{"subitem_subject":"系統的肝亜区域切除"},{"subitem_subject":"門脈塞栓術"},{"subitem_subject":"Hepatocellular carcinoma","subitem_subject_language":"en"},{"subitem_subject":"hepatic resection","subitem_subject_language":"en"},{"subitem_subject":"liver transplantation","subitem_subject_language":"en"},{"subitem_subject":"systematic subsegmentectomy","subitem_subject_language":"en"},{"subitem_subject":"portal embolization","subitem_subject_language":"en"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"肝癌の外科的治療 : 肝移植も含めて","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"肝癌の外科的治療 : 肝移植も含めて"},{"subitem_title":"Surgical Treatment of Hepatocellular Carcinoma","subitem_title_language":"en"}]},"item_type_id":"2","owner":"3","path":["35"],"pubdate":{"attribute_name":"公開日","attribute_value":"2017-05-24"},"publish_date":"2017-05-24","publish_status":"0","recid":"405","relation_version_is_last":true,"title":["肝癌の外科的治療 : 肝移植も含めて"],"weko_creator_id":"3","weko_shared_id":3},"updated":"2023-06-20T16:29:47.451684+00:00"}